The fall of the Diabetes pump.

[kc]

Interesting story about J & J quitting the pump business. It leaves MDT and a couple of weak companies behind in the business.   This hopefully is going to be a positive for MannKind as some patients have ditched the pump.   Worth reading this story published today.  Makes mention of Al Mann and selling his pump business to MDT. 

Al Mann knew the value of the pump business in 2001 and I believe that MannKind management & the board know that value in 2017.

www.latimes.com/business/lazarus/la-fi-lazarus-diabetes-animas-20171017-story.html

 

Patients face tough choices when a healthcare provider calls it quits

In my case, J&J said its “partner of choice” is Medtronic, which means it’s steering its 90,000 customers to the industry leader.

Medtronic, the world's largest stand-alone medical device maker, acquired its Northridge-based MiniMed pump business in 2001 from Los Angeles entrepreneur Alfred Mann for nearly $3.3 billion.

[sayhey24]

Well, Al predicted this would happen at the 26:50m. Then again he outlined the label which was just approved at 36m.
www.youtube.com/watch?v=muBuxTqxmQo

Lets hope he is right with his afrezza prediction.

[kc]

I guess I had never seen that 2010 presentation. But I now understand why the injected insulin producers and the pump companies hate MannKind.

Afrezza is so just DISRUPTIVE to their profit chain they will do anything to kill the product and the company.